Portal to collate data on spurious drugs in works

A unified portal which will maintain a database of drugs that are not of standard quality or are spurious is in the offing.

With an aim to build trust on the quality of drugs in the domestic and global markets, India's drug regulatory organisation is all set to introduce a new unified portal for developing a digital drugs regulatory system (DRS).

The drug regulator has asked for suggestions from various government agencies over the proposed portal including all state drug controllers, customs, ministry of environment, drug manufacturing associations, Indian Council of Medical research, Bureau of Indian Standards (BIS), among others.